ICAC mark to be made mandatory as quality benchmark of medical devices sold in India.

Aurobindo lost the $400 million AIDS drugs contract to South African rival firms –Aspen and Adcock- despite a 30% discount

Medicis settled a similar patent dispute with Perrigo in April 2009.

US sales contribute about a third of Sun Pharma's overall revenue

Ralfinamide from Newron, which promises the least side-effects, is on way; Pfizer, AstraZeneca & Merck are exploring potential drugs to block the Nav1.7 channel.

Natco’s generic granisetron pills to treat nausea in cancer patients gets US FDA approval.

PFC India will offer study planning, monitoring, audit and data management services to life science companies across the world.

Solifenacin has lesser side-effects than other leading drugs to treat inability to control urination.

Japan’s leading drug maker Astellas Pharma Inc is planning to establish full-scale operations in Indian pharma market.

The Union Finance Ministry is urged to cut down duties on cancer/AIDS medicines in forthcoming budget.